Increased 5-Hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study

Journal of Clinical Psychopharmacology

Volumn 21, Issue 1, 2001, Pages 53-58

  Zanardi, Raffaella ^a   Artigas, Francesc ^b   Moresco, Rosamaria ^c   Colombo, Cristina ^a   Messa, Cristina ^b   Gobbo, Clara ^b   Smeraldi, Enrico ^a   Fazio, Ferruccio ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b INST D INVESTIGACIONS B   (Spain)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; PAROXETINE; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AGE; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; DEPRESSION; FEMALE; FRONTAL CORTEX; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; RECEPTOR BINDING; TREATMENT OUTCOME;

ADULT; DEPRESSION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; PAROXETINE; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SPIPERONE; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0035141921     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200102000-00010     Document Type: Article

References (49)

1. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
2. 1A antagonists
3. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors
4. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression
5. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine andtidepressant treatment
6. Paroxetine and pindolol. A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
7. How long should pindolol be associated with paroxetine to improve the antidepressant response?
8. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression. A controlled study
9. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of a double-blind, placebo-controlled trial
10. Mechanism of action of antidepressant treatments, implications for the etiology and treatment of depressive disorders
11. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system
12. Clinical and biochemical aspects of depressive disorders. II. Transmitter/receptor theories
13. Current advances and trends in the treatment of depression
14. 1A agonist
15. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
16. 2 receptors
17. 2-receptor function in the brain of the guinea pig
18. 2 receptors in rat brain: An autoradiographic study
19. 5-Hydroxytryptamine(2) and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination
20. 2 receptors in the rat brain
21. No carrier added 3-(2′-F-18)fluoroethylspiperone, a new dopamine receptor binding tracer for positron emission tomography
22. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
23. 3H]spiroperidol
24. 3H]spiperone binding to rat brain regions
25. 2 serotonin receptors in vivo with 3-N-(2′-F18)fluoroethylspiperone and positron emission tomography
26. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: Specificity analysis and comparison with in vitro binding
27. 2 recognition sites
28. 2 dopamine receptors in the human brain
29. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain
30. 2 receptor mediated c-fos gene expression
31. 2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats
32. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice
33. 2 receptor number
34. Chronic electroconvulsive seizures increase the expression of serotonin(2) receptor messenger RNA in rat frontal cortex
35. 2 binding sites in the frontal cortex of suicide victims and control subjects
36. 2 and β-adrenergic receptor binding sites in the brain of suicide victims
37. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala
38. 2 receptor binding sites in depressed suicide victims
39. 2 receptors in suicide victims
40. 2 receptors in suicide victims: Violence of death, depression and effects of antidepressant treatment
41. 2A receptors on interneurons in rat piriform cortex
42. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells
43. Immunocytochemical localization and description of neurons expressing serotonin(2) receptors in the rat brain
44. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
45. 1A receptors mediate opposing responses on membrane excitability in rat association cortex
46. Immunocytochemical localization of serotonin(1A) receptors in the rat central nervous system
47. A molecular and cellular theory of depression
48. 2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex
49. Cingulate function in depression: A potential predictor of treatment response